Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001968202-24-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-16 | 2024-02-14 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale | $942.28 | -10.4K | 21.6K | -33% | -$9.83M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | S | D | 275 | $941.41 | 24,861 | D | — | — | (F5) Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-02-14 | S | D | 375 | $950.45 | 20,578 | D | — | — | (F12) Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-02-14 | S | D | 112 | $949.07 | 20,953 | D | — | — | (F11) Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-02-14 | S | D | 150 | $948.70 | 21,065 | D | — | — | (F10) Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-02-14 | S | D | 240 | $947.81 | 21,215 | D | — | — | (F9) Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-02-14 | S | D | 95 | $945.81 | 21,455 | D | — | — | (F8) Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-02-14 | S | D | 439 | $937.94 | 30,373 | D | — | — | (F1) Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-02-14 | S | D | 226 | $938.13 | 30,147 | D | — | — | (F2) Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-02-14 | S | D | 750 | $939.60 | 29,397 | D | — | — | (F3) Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-02-14 | S | D | 4,261 | $940.44 | 25,136 | D | — | — | (F4) Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-02-14 | S | D | 200 | $951.77 | 20,378 | D | — | — | (F13) Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-02-14 | S | D | 2,691 | $943.51 | 22,170 | D | — | — | (F6) Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-02-14 | S | D | 620 | $944.30 | 21,550 | D | — | — | (F7) Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price. |